GH-axis + recovery stack

BPC-157 + Sermorelin stack

A research-context overview of stacking BPC-157 with Sermorelin: the rationale, complementary benefits, side-effect overlap, and pharmacokinetic considerations. Educational only — never a recommendation.

Why this stack?

Pairing a Performance peptide like Sermorelin with a Recovery peptide like BPC-157 is one of the most common stack archetypes in the research literature. The Performance compound drives the GH/IGF-1 axis or anabolic signaling; the Recovery compound shortens the soft-tissue and inflammation tax of training, letting the anabolic signal land on healthier tissue. The two work on independent pathways, so timing concerns are minimal — most researchers dose them on separate clocks.

Recovery

BPC-157

The recovery king; speeds up tendon, muscle, and gut healing for faster training turnarounds.

Key benefits

  • Speeds up tendon healing
  • Accelerates muscle recovery
  • Promotes gut healing
  • Reduces inflammation

Side effects to watch

  • Minimal reported side effects
  • Rare mild injection site reactions
Reference dose
250-500 mcg · Twice daily (AM/PM)
Performance

Sermorelin

Mimics natural GH pulses to build lean mass and improve sleep/recovery.

Key benefits

  • Increases lean body mass
  • Improves sleep quality
  • Reduces body fat
  • Enhances immune function

Side effects to watch

  • Flushing
  • Headache
  • Nausea
Reference dose
200-500 mcg · Daily (at bedtime)

Half-life considerations

BPC-157 clears at roughly t½ 4 h, while Sermorelin clears at roughly t½ 12 min. BPC-157 accumulates over multiple days while Sermorelin is essentially gone between doses — typical of a long-residence + pulse stack. Most researchers dose them on independent schedules.

Profile
BPC-157
Profile
Sermorelin
Compare
BPC-157 vs Sermorelin

Educational use only

This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.